One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis | Zendy

Susan Swindells | Zendy; Ritesh Ramchandani | Zendy; Amita Gupta | Zendy; Constance A. Benson | Zendy; Jorge Leon-Cruz | Zendy; Noluthando Mwelase | Zendy; Marc Antoine Jean Juste | Zendy; Javier R. Lama | Zendy; Javier Valencia | Zendy; Ayotunde Omoz-Oarhe | Zendy; Khuanchai Supparatpinyo | Zendy; Gaerolwe Masheto | Zendy; Lerato Mohapi | Zendy; Rodrigo Escada | Zendy; Sajeeda Mawlana | Zendy; Peter Banda | Zendy; Patrice Sévère | Zendy; James Hakim | Zendy; Cecilia Kanyama | Zendy; Deborah Langat | Zendy; Laura Moran | Zendy; Janet Andersen | Zendy; Courtney V. Fletcher | Zendy; Eric L. Nuermberger | Zendy; Richard E. Chaisson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Author(s) -

Susan Swindells,

Ritesh Ramchandani,

Amita Gupta,

Constance A. Benson,

Jorge Leon-Cruz,

Noluthando Mwelase,

Marc Antoine Jean Juste,

Javier R. Lama,

Javier Valencia,

Ayotunde Omoz-Oarhe,

Khuanchai Supparatpinyo,

Gaerolwe Masheto,

Lerato Mohapi,

Rodrigo Escada,

Sajeeda Mawlana,

Peter Banda,

Patrice Sévère,

James Hakim,

Cecilia Kanyama,

Deborah Langat,

Laura Moran,

Janet Andersen,

Courtney V. Fletcher,

Eric L. Nuermberger,

Richard E. Chaisson

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1806808

Subject(s) - rifapentine , isoniazid , tuberculosis , medicine , human immunodeficiency virus (hiv) , virology , mycobacterium tuberculosis , latent tuberculosis , pathology

Tuberculosis is the leading killer of patients with human immunodeficiency virus (HIV) infection. Preventive therapy is effective, but current regimens are limited by poor implementation and low completion rates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research